Loading...
Market
Will gene-edited pig kidney transplant trials include more than 10 patients by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Announcements from medical institutions or research publications
Story
Alabama Woman, 53, Freed from Eight Years of Dialysis After Third Gene-Edited Pig Kidney Transplant in Late November
Dec 17, 2024, 03:22 PM
An Alabama woman, aged 53, is recovering well after receiving a gene-edited pig kidney transplant last month at NYU Langone Health. This transplant has freed her from eight years of dialysis, marking her as the third person to undergo such an experimental procedure. The surgery took place in late November and is part of ongoing efforts to explore xenotransplantation as a solution for organ shortages. Previous recipients of pig organs have faced severe complications, with all having died within two months post-transplant. However, the current recipient's condition is reported as 'extraordinary,' raising hopes for improved outcomes in future xenotransplant trials.
View original story
Similar markets
Less than 10 • 25%
10 to 20 • 25%
21 to 50 • 25%
More than 50 • 25%
Yes • 50%
No • 50%
0-5 transplants • 25%
6-10 transplants • 25%
11-20 transplants • 25%
More than 20 transplants • 25%
1-3 • 25%
4-6 • 25%
7-9 • 25%
10 or more • 25%
NYU Langone • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Other • 25%
Yes • 50%
No • 50%
Rejection issues • 25%
Infection complications • 25%
Ethical concerns • 25%
Other challenges • 25%
Yes • 50%
No • 50%
0-5 • 25%
6-10 • 25%
11-20 • 25%
More than 20 • 25%
Less than 5 • 25%
5 to 10 • 25%
11 to 20 • 25%
More than 20 • 25%